By continuing to use our site, you are agreeing for us to set a small number of cookies. Cookie policy

Agenda and minutes

Venue: Committee Room 3 - Senedd. View directions

Contact: Llinos Madeley 

Senedd.TV: View the webcast

Items
Note No. Item

Transcript

(09.00 - 09.45)

1.

The Committee's forward work programme

Supporting documents:

Minutes:

1.1 The Committee agreed to undertake an inquiry into alcohol and substance misuse. Members considered and agreed the terms of reference and the Committee’s approach to the inquiry.

(09.45)

2.

Introductions, apologies and substitutions

Minutes:

2.1 Apologies were received from Lynne Neagle. Ann Jones acted as a substitute.

(09.45 - 10.30)

3.

Inquiry into new psychoactive substances (“legal highs”): Evidence session 1

Jeremy Sare, Angelus Foundation

Maryon Stewart, Angelus Foundation

Harry Shapiro, DrugScope

Supporting documents:

Minutes:

3.1 Apologies were received from Maryon Stewart.

3.2 The witnesses responded to questions from Members.

(10.45 - 11.30)

4.

Inquiry into new psychoactive substances (“legal highs”): Evidence session 2

Professor Philip Routledge OBE, Chair of the Programme Board, Welsh Emerging Drugs and Identification of Novel Substances (WEDINOS)

Josephine Smith, Programme Lead, WEDINOS

Dr Quentin Sandifer, Public Health Wales

Supporting documents:

Minutes:

4.1 The witnesses responded to questions from Members.

4.2 Dr Quentin Sandifer agreed to supply the Committee with additional information about how Public Health Wales engages and communicates with communities in Wales about new psychoactive substances.

4.3 The Committee agreed to write to TICTAC to seek clarification on whether they test the substances received in addition to providing visual drug identification.

(11.30 - 12.15)

5.

Inquiry into new psychoactive substances (“legal highs”): Evidence session 3

Joanne Davies, Assistant Director of Planning, Abertawe Bro Morgannwg University Health Board

Jamie Harris, Families Children and Young Persons Services Manager, SANDS Cymru (formerly known as Swansea Drugs Project)*

Nicola John, Director Public Health, Cwm Taf University Health Board*

Dr Julia Lewis, Consultant Addiction Psychiatrist and Clinical Lead for Addiction, Aneurin Bevan University Health Board

Dr Jonathan Whelan, Assistant Medical Director, Welsh Ambulance Service NHS Trust*

 

*Written papers have not been submitted

Supporting documents:

Minutes:

5.1 The witnesses responded to questions from Members.

(13.15 - 14.15)

6.

Inquiry into new psychoactive substances (“legal highs”): Evidence session 4

Kathryn Peters, Community Safety Manager for Caerphilly County Borough Council

Councillor Mark Child, Trading Standards portfolio holder Swansea Council Councillor

Andrea Lewis, Swansea Council

Angela Cronin, Development Worker for Health & Wellbeing, Bridgend Youth Service

Richard Webb, Association of Chief Trading Standards Officers, Oxfordshire County Council

Supporting documents:

Minutes:

6.1 Apologies were received from Councillor Mark Child. Jackie Garland acted as substitute.

6.2 The witnesses responded to questions from Members.

6.3 Richard Webb agreed to provide further information about a toolkit that is being developed by trading standards officers on how to approach the issue of new psychoactive substances. He also agreed to provide a view in writing about the impact of the Anti-Social Behaviour Crime and Policing Act 2014 on trading standards officers’ approach to new psychoactive substances.

(14.15)

7.

Papers to note

Supporting documents:

Minutes:

7.0a The Committee noted the minutes of the meetings on 16 and 22 October.

7.1

Inquiry into new psychoactive substances (“legal highs”): Note from the visits held on 2 October 2014

Supporting documents:

Minutes:

7.1a The Committee noted the note of the visits held on 2 October 2014 in relation to the inquiry into new psychoactive substances (“legal highs”).

7.2

Inquiry into new psychoactive substances (“legal highs”): Note from the focus group events held on 2 October 2014

Supporting documents:

Minutes:

7.2a The Committee noted the note of the focus groups held on 2 October 2014 in relation to the inquiry into new psychoactive substances (“legal highs”).

7.3

Inquiry into new psychoactive substances (“legal highs”): Results of the Committee's survey

Supporting documents:

Minutes:

7.3a The Committee noted the results of the Committee’s survey in relation to the inquiry into new psychoactive substances (“legal highs”).

7.4

Inquiry into new psychoactive substances (“legal highs”): Consultation responses

Supporting documents:

Minutes:

7.4a The Committee noted the consultation responses in relation to the inquiry into new psychoactive substances (“legal highs”).

7.5

Public Health White Paper: Follow up from 8 October 2014

Supporting documents:

Minutes:

7.5a The Committee noted the responses from both the Minister for Health and Social Services and the Chief Medical Officer in relation to the factual briefing on the Public Health White Paper.

7.6

Correspondence from the Petitions Committee: P-04-568 Public Inquiry into ABMU Health Board

Supporting documents:

Minutes:

7.6a The Committee agreed to write to the Chair of Petitions Committee to inform the Petitions Committee that although this is not a matter the Health and Social Care Committee is considering currently, the Public Accounts Committee is undertaking a piece of work on health board governance in NHS Wales The Health and Social Care Committee agreed to await the outcome of that inquiry before considering the matter further.

(14.15)

8.

Motion under Standing Order 17.42(vi) to resolve to exclude the public from the remainder of the meeting

Minutes:

8.1 The motion was agreed.

(14.15 - 14.45)

9.

Inquiry into new psychoactive substances (“legal highs”): Consideration of evidence received

Minutes:

9.1 The Committee considered the evidence received on the inquiry.

 

 

You are in :

  1. Home
  2. Assembly Business

Partners & Help